US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

14.12

+0.35002.54%

Post-market: 14.400.2800+1.98%18:13 EDT

Volume:1.11M

Turnover:15.33M

Market Cap:898.00M

PE:-6.03

High:14.17

Open:13.86

Low:13.31

Close:13.77

52wk High:28.00

52wk Low:8.16

Shares:63.60M

Float Shares:47.12M

Volume Ratio:1.48

T/O Rate:2.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3433

EPS(LYR):-3.1931

ROE:-89.18%

ROA:-33.59%

PB:0.31

PE(LYR):-4.42

Loading ...

Overview Company News Filings

Jade Biosciences plans underwritten public offering of common stock, pre-funded warrants

Jade Biosciences - Net Proceeds to Fund Clinical Trials, Preclinical Studies, and Corporate Purposes

THOMSON REUTERS

Jade Biosciences Announces Proposed Underwritten Public Offering

THOMSON REUTERS

Wedbush Keeps Their Buy Rating on Jade Biosciences (JBIO)

Harrison Lifts JBIO Price Target to $74 on Promising JADE101 Data and Attractive IgA Nephropathy Opportunity

Jefferies says Jade Biosciences JADE101 data came in line with bull case

Wedbush Raises Price Target on Jade Biosciences to $45 From $34, Maintains Outperform Rating

MT Newswires Live

Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.

Analysts Are Bullish on Top Healthcare Stocks: Aligos Therapeutics (ALGS), Jade Biosciences (JBIO)

Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $55 From $45

THOMSON REUTERS

Jade Biosciences Reports Positive Interim Results in Trial of IgA Nephropathy Drug; Shares Rise

MT Newswires Live

BRIEF-Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101

Jade Biosciences - Phase 3 Registrational Trial Expected to Initiate in First Half of 2027

THOMSON REUTERS

Jade Biosciences - Jade101 Well-Tolerated Across All Evaluated Doses

THOMSON REUTERS

Jade Biosciences - Jade101 Sustains ~70% Iga Reduction at 12 Weeks After Single Dose

THOMSON REUTERS

Jade Biosciences reports positive interim Phase 1 data for JADE101 in IgA nephropathy, targets Q12W dosing

Jade Biosciences to present interim Phase 1 healthy volunteer data for JADE101 in IgA nephropathy on June 1 webcast

Jade Biosciences’ JADE101 Trial Opens a New Front in IgA Nephropathy Investing

Guggenheim Sticks to Their Buy Rating for Jade Biosciences (JBIO)

Jade Biosciences Price Target Maintained With a $39.00/Share by BTIG

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/JBIO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":14.12,"timestamp":1790971200000,"preClose":13.77,"halted":0,"volume":1109845,"hourTrading":{"tag":"盘后","latestPrice":14.4,"preClose":14.12,"latestTime":"18:13 EDT","volume":25226,"amount":356206.50785999995,"timestamp":1790979222269,"change":0.28,"changeRate":0.01983,"amplitude":0.01983},"delay":0,"changeRate":0.025417574437182254,"floatShares":47122000,"shares":63597387,"eps":-2.343303,"marketStatus":"Post-Mkt","change":0.35,"latestTime":"10-02 18:18:17 EDT","open":13.86,"high":14.17,"low":13.31,"amount":15334121.279785,"amplitude":0.062455,"askPrice":18.34,"askSize":100,"bidPrice":13.76,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-2.343303,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":13.77,"preHourTrading":{"tag":"盘前","latestPrice":13.88,"preClose":13.77,"latestTime":"09:29 EDT","volume":228,"amount":3162.818052,"timestamp":1790947799999,"change":0.11,"changeRate":0.007988,"amplitude":0.145243},"postHourTrading":{"tag":"盘后","latestPrice":14.4,"preClose":14.12,"latestTime":"18:13 EDT","volume":25226,"amount":356206.50785999995,"timestamp":1790979222269,"change":0.28,"changeRate":0.01983,"amplitude":0.01983},"volumeRatio":1.477152,"impliedVol":1.1016,"impliedVolPercentile":0.7849},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":47122000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":1.477152,"shares":63597387,"dividePrice":0,"high":14.17,"amplitude":0.062455,"preClose":13.77,"low":13.31,"week52Low":8.16,"pbRate":"0.31","week52High":28,"institutionHeld":0,"latestPrice":14.12,"committee":-0.785714,"eps":-2.343303,"divideRate":0,"volume":1109845,"delay":0,"ttmEps":-2.343303,"open":13.86,"prevYearClose":15.43,"prevWeekClose":14.42,"prevMonthClose":14.05,"prevQuarterClose":14.05,"fiveDayClose":14.42,"twentyDayClose":19.85,"sixtyDayClose":22.48,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"JBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1781496000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-10-01","current":-5.893391,"percent":0.563218,"low":-10.392766,"twenty":-8.786661,"median":-6.448364,"eighty":-2.874869,"high":-2.319279,"avg":-5.945451,"sd":2.630204,"marketCap":893543287},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-05","current":-6.756045,"twenty":-7.480494,"median":-5.23899,"eighty":-2.696728,"marketCap":875644182},{"date":"2026-06-12","current":-7.36451,"twenty":-7.480494,"median":-5.370563,"eighty":-2.700201,"marketCap":954506790},{"date":"2026-06-18","current":-7.726324,"twenty":-7.487348,"median":-5.393787,"eighty":-2.710604,"marketCap":1001401091},{"date":"2026-06-26","current":-9.988804,"twenty":-7.591639,"median":-5.407335,"eighty":-2.731778,"marketCap":1294638873},{"date":"2026-07-02","current":-9.988804,"twenty":-7.673406,"median":-5.426688,"eighty":-2.743259,"marketCap":1294638873},{"date":"2026-07-10","current":-10.295658,"twenty":-7.795377,"median":-5.444106,"eighty":-2.744648,"marketCap":1334409990},{"date":"2026-07-17","current":-9.379675,"twenty":-7.921008,"median":-5.585386,"eighty":-2.752288,"marketCap":1215690240},{"date":"2026-07-24","current":-8.985802,"twenty":-8.046029,"median":-5.655171,"eighty":-2.766178,"marketCap":1164640747},{"date":"2026-07-31","current":-9.159838,"twenty":-8.108193,"median":-5.875502,"eighty":-2.788402,"marketCap":1187197500},{"date":"2026-08-07","current":-10.18574,"twenty":-8.267967,"median":-5.948946,"eighty":-2.798819,"marketCap":1320163620},{"date":"2026-08-14","current":-9.881583,"twenty":-8.338317,"median":-6.086042,"eighty":-2.805764,"marketCap":1514253784},{"date":"2026-08-21","current":-8.810836,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"marketCap":1350172526},{"date":"2026-08-28","current":-8.835737,"twenty":-8.844495,"median":-6.229853,"eighty":-2.840774,"marketCap":1353988369},{"date":"2026-09-04","current":-8.238111,"twenty":-8.852338,"median":-6.276995,"eighty":-2.844205,"marketCap":1262408131},{"date":"2026-09-11","current":-7.943448,"twenty":-8.846064,"median":-6.423883,"eighty":-2.855122,"marketCap":1217253987},{"date":"2026-09-18","current":-7.113412,"twenty":-8.837489,"median":-6.471481,"eighty":-2.857913,"marketCap":1090059213},{"date":"2026-09-25","current":-6.113218,"twenty":-8.815816,"median":-6.487254,"eighty":-2.866667,"marketCap":936789510},{"date":"2026-10-01","current":-5.831006,"twenty":-8.786661,"median":-6.448364,"eighty":-2.874869,"marketCap":893543287}],"updateTime":1790959079867},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640189743","title":"Jade Biosciences plans underwritten public offering of common stock, pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189743","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189743?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516901,"startTime":"0","endTime":"0","summary":"Jade Biosciences launched a proposed underwritten public offering of common stock or pre-funded warrants in lieu of common stock.Underwriters get a 30-day option to buy up to 15% more securities at the offering price, less discounts and commissions.Proceeds earmarked for clinical trials, preclinical studies, manufacturing support, research and development, capital spending, working capital.Jefferies, TD Cowen, UBS Investment Bank named joint book-runners; LifeSci Capital also a book-runner; BTIG lead manager.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9nYVYd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4539","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4588","IE00B3QW5Z07.USD","LU0314104364.USD","BK4112","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","BK4139","SG9999014013.SGD","IE00BN0W2V16.EUR","JBIO","LU2210150020.SGD","SG9999014021.USD","LU2210149790.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189765","title":"Jade Biosciences - Net Proceeds to Fund Clinical Trials, Preclinical Studies, and Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189765?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1RTQKS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189762","title":"Jade Biosciences Announces Proposed Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189762?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:01","pubTimestamp":1780516860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA1RTQKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943300","title":"Wedbush Keeps Their Buy Rating on Jade Biosciences (JBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943300","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640943300?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:38","pubTimestamp":1780403916,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico maintained a Buy rating on Jade Biosciences today and set a price target of $45.00. According to TipRanks, Chico is a 5...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640917107","title":"Harrison Lifts JBIO Price Target to $74 on Promising JADE101 Data and Attractive IgA Nephropathy Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917107","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917107?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:16","pubTimestamp":1780398977,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison has maintained their bullish stance on JBIO stock, giving a Buy rating yesterday. Julian Harrison has given his Buy ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/harrison-lifts-jbio-price-target-to-74-on-promising-jade101-data-and-attractive-iga-nephropathy-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/harrison-lifts-jbio-price-target-to-74-on-promising-jade101-data-and-attractive-iga-nephropathy-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640961256","title":"Jefferies says Jade Biosciences JADE101 data came in line with bull case","url":"https://stock-news.laohu8.com/highlight/detail?id=2640961256","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640961256?lang=en_us&edition=fundamental","pubTime":"2026-06-02 03:40","pubTimestamp":1780342808,"startTime":"0","endTime":"0","summary":"Jefferies noted that Jade Biosciences (JBIO)’ interim JADE101 trial data hit the firm’s bull case expectations. The firm added that management sees...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jefferies-says-jade-biosciences-jade101-data-came-in-line-with-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jefferies-says-jade-biosciences-jade101-data-came-in-line-with-bull-case-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640680719","title":"Wedbush Raises Price Target on Jade Biosciences to $45 From $34, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2640680719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640680719?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:34","pubTimestamp":1780328080,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) has an average rating of buy and mean price target of $38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640462950","title":"Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2640462950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640462950?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:36","pubTimestamp":1780324560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 10:36 ET (14:36 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640761950","title":"Analysts Are Bullish on Top Healthcare Stocks: Aligos Therapeutics (ALGS), Jade Biosciences (JBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640761950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640761950?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:30","pubTimestamp":1780324206,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aligos Therapeutics (ALGS) and Jade Biosciences (JBI...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-aligos-therapeutics-algs-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-aligos-therapeutics-algs-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JBIO","BK4539","ALGS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640018951","title":"Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $55 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2640018951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640018951?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:42","pubTimestamp":1780317739,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nAZN4SZUDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640495920","title":"Jade Biosciences Reports Positive Interim Results in Trial of IgA Nephropathy Drug; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2640495920","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640495920?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:02","pubTimestamp":1780315356,"startTime":"0","endTime":"0","summary":"Jade Biosciences  said Monday that interim phase 1 trial results showed its experimental immunoglobulin A nephropathy treatment, JADE101, delivered rapid, deep and sustained reductions in IgA levels in healthy volunteers.The company said JADE101 achieved about 70% reductions in IgA levels that were sustained for 12 weeks at the 700 mg dose. The therapy was generally well tolerated across all tested dose levels, with no serious adverse events or study discontinuations reported, the company said.Jade said the data suggest JADE101 could potentially be administered once every 12 weeks, supporting a more convenient dosing schedule than existing therapies.Shares of Jade Biosciences were 9.8% higher in premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640956697","title":"BRIEF-Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101","url":"https://stock-news.laohu8.com/highlight/detail?id=2640956697","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640956697?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:21","pubTimestamp":1780312866,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 June 1 (Reuters) - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES - JADE101 SUSTAINS ~70% IGA REDUCTION AT 12 WEEKS AFTER SI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42805I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640955498","title":"Jade Biosciences - Phase 3 Registrational Trial Expected to Initiate in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2640955498","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640955498?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:04","pubTimestamp":1780311843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42805I:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640554919","title":"Jade Biosciences - Jade101 Well-Tolerated Across All Evaluated Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2640554919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640554919?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:04","pubTimestamp":1780311843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42805I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640554649","title":"Jade Biosciences - Jade101 Sustains ~70% Iga Reduction at 12 Weeks After Single Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2640554649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640554649?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:04","pubTimestamp":1780311843,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN42805I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995516","title":"Jade Biosciences reports positive interim Phase 1 data for JADE101 in IgA nephropathy, targets Q12W dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995516","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640995516?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:02","pubTimestamp":1780311756,"startTime":"0","endTime":"0","summary":"Jade Biosciences disclosed positive interim Phase 1 results for JADE101 in IgA nephropathy; data will be presented at the ERA Congress in June 2026.The study showed rapid, sustained biomarker improvement with a safety profile consistent with the drug class, supporting a less frequent dosing approach.A Phase 2 trial in IgA nephropathy is underway with interim clinical readouts expected in 2027.A registrational Phase 3 trial is planned to start in the first half of 2027, pending FDA requirements.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL7NqK7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672265","title":"Jade Biosciences to present interim Phase 1 healthy volunteer data for JADE101 in IgA nephropathy on June 1 webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672265","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672265?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:05","pubTimestamp":1780085123,"startTime":"0","endTime":"0","summary":"Jade Biosciences scheduled a June 1, 2026, conference call to present interim Phase 1 healthy-volunteer results for JADE101.JADE101 is an anti-APRIL monoclonal antibody being developed for IgA nephropathy as a potentially differentiated, disease-modifying therapy.The interim readout is expected to guide dosing strategy and further shape the drug’s clinical profile ahead of later-stage development decisions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL9C10MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014021.USD","BK4139","SG9999014039.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","JBIO","NDAQ","BK4112","BK4585","SG9999014013.SGD","BK4588","BK4539","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639367977","title":"Jade Biosciences’ JADE101 Trial Opens a New Front in IgA Nephropathy Investing","url":"https://stock-news.laohu8.com/highlight/detail?id=2639367977","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639367977?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:33","pubTimestamp":1780072438,"startTime":"0","endTime":"0","summary":"Jade Biosciences, Inc. ($JBIO) announced an update on their ongoing clinical study. The Phase 2 JUNIPER study from Jade Biosciences, Inc. focuses o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-jade101-trial-opens-a-new-front-in-iga-nephropathy-investing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-jade101-trial-opens-a-new-front-in-iga-nephropathy-investing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688307","title":"Guggenheim Sticks to Their Buy Rating for Jade Biosciences (JBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688307","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688307?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:39","pubTimestamp":1779885547,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Vamil Divan reiterated a Buy rating on Jade Biosciences yesterday and set a price target of $32.00. The company’s shares closed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638350137","title":"Jade Biosciences Price Target Maintained With a $39.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2638350137","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638350137?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:36","pubTimestamp":1779878160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 06:36 ET (10:36 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":116,"code":"91000000","status":"200"}]}}